Cough and cold medicines should not be given to children under sixChildren under six years of age should not be given over-the-counter (OTC) cough and cold medication, a new Health Canada advisory said. Detailed discharge plan reduces returns to hospitalImplementing standardized process of patient education could improve outcomes and save health-care system money Botox not the first choice, but still good for muscle spasm Canada In Brief Ethics poll of Canadian MDs finds strongly held views Big responses seen for right to not offer procedures due to religious beliefs and condemning deception ‘in patient’s best interest’ Clinical In Brief LETTER: Another view on pharma rep detailing B.C. government and BCPhA announce drug-pricing agreement B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy. New pediatric indication for Reyataz Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age. Phase 1 of Alberta's new Pharmaceutical Strategy introduced Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8. First Previous 1256 1257 1258 1259 1260 Next Last
